1. Home
  2. GF vs VRXA Comparison

GF vs VRXA Comparison

Compare GF & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Germany Fund Inc. (The)

GF

New Germany Fund Inc. (The)

N/A

Current Price

$9.80

Market Cap

164.5M

Sector

Finance

ML Signal

N/A

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.06

Market Cap

161.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GF
VRXA
Founded
1990
2021
Country
Germany
Germany
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
161.2M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
GF
VRXA
Price
$9.80
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.2K
★ 142.5K
Earning Date
01-01-0001
N/A
Dividend Yield
★ 0.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.88
$0.90
52 Week High
$12.49
$4.50

Technical Indicators

Market Signals
Indicator
GF
VRXA
Relative Strength Index (RSI) 32.04 45.85
Support Level N/A $0.92
Resistance Level $11.82 $1.29
Average True Range (ATR) 0.23 0.10
MACD -0.04 0.01
Stochastic Oscillator 4.50 32.57

Price Performance

Historical Comparison
GF
VRXA

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investments includes investments in different sectors such as the industrials, information technology, materials, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: